TN

Thathireddy Narsihma Reddy

Director Director DIN 07538313
DIN 07538313 First appointment Jul 2016 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies –
Past companies 1 historical roles
Total affiliations 1 Since Jul 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Thathireddy Narsihma Reddy

Data last updated:

Thathireddy Narsihma Reddy has 10 years in corporate governance. Formerly with 1 company, such as Concord Drugs Limited. Engaged in General Business. Contributes to corporate operations.

DIN 07538313
Primary Designation Director
First Appointment 16 Jul 2016
Oldest Company Age –

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Concord Drugs Limited L24230TG1995PLC020093
Managing Director16 Jul 20161995₹45.26 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Concord Drugs Limited
Premium access

Shareholding and investment profile for Thathireddy Narsihma Reddy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Thathireddy Narsihma Reddy

Thathireddy Narsihma Reddy has 10 years in corporate governance. Formerly with 1 company, such as Concord Drugs Limited. Engaged in General Business. Contributes to corporate operations.

Thathireddy Narsihma Reddy has expertise in General Business.

Thathireddy Narsihma Reddy has 10 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available